Potential conflict of interest: Nothing to report.
Epigenetic silencing of DACH1 induces loss of transforming growth factor-β1 antiproliferative response in human hepatocellular carcinoma
Article first published online: 21 OCT 2013
Copyright © 2013 by the American Association for the Study of Liver Diseases
Volume 58, Issue 6, pages 2012–2022, December 2013
How to Cite
Zhu, H., Wu, K., Yan, W., Hu, L., Yuan, J., Dong, Y., Li, Y., Jing, K., Yang, Y. and Guo, M. (2013), Epigenetic silencing of DACH1 induces loss of transforming growth factor-β1 antiproliferative response in human hepatocellular carcinoma. Hepatology, 58: 2012–2022. doi: 10.1002/hep.26587
Supported by grants from the National Basic Research Program of China (973 Program Nos. 2012CB934002, 2010CB912802); National High-tech R&D Program of China (863 Program Nos. SS2012AA020314, SS2012AA020821, SS2012AA020303); National Key Scientific Instrument Special Programme of China (Grant No. 2011YQ03013405); National Science Foundation of China (Grant Nos. 81121004, 81071953, 81161120432, 81072169, 81172422, 81261120395).
- Issue published online: 26 NOV 2013
- Article first published online: 21 OCT 2013
- Accepted manuscript online: 20 JUN 2013 08:23AM EST
- Manuscript Accepted: 9 JUN 2013
- Manuscript Received: 20 JAN 2013
Additional Supporting Information may be found in the online version of this article.
|hep26587-sup-0001-suppInfo.doc||51K||Supporting Table 1. Clinical features and DACH1 methylation status in HCC patients|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.